Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer

Tse-Ying Huang, Chih-Yuan Wang, Kuen-Yuan Chen, Li-Ting Huang

Open source

DOI
10.3389/fendo.2020.00382
Published
2020-06-16
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2020.00382,
  title = {Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer},
  author = {Tse-Ying Huang and Chih-Yuan Wang and Kuen-Yuan Chen and Li-Ting Huang},
  year = {2020},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2020.00382},
  url = {https://doi.org/10.3389/fendo.2020.00382}
}

RIS

TY  - JOUR
TI  - Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer
AU  - Tse-Ying Huang
AU  - Chih-Yuan Wang
AU  - Kuen-Yuan Chen
AU  - Li-Ting Huang
PY  - 2020
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2020.00382
UR  - https://doi.org/10.3389/fendo.2020.00382
ER  - 

APA

Huang, T., Wang, C., Chen, K., & Huang, L. (2020). Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2020.00382

Source records